Ana Velázquez Mañana: Why is advocating for Cancer Research funding is everyone’s responsibility?

Ana Velázquez Mañana shared on X/Twitter:

“Why is advocating for Cancer Research funding everyone’s responsibility?

Cancer affects everyone

National Cancer Institute has 13% less buying power in 2023 compared with 2003

That means MOST research ideas, potential cures, and interventions that can improve the lives of people with cancer go unfunded.

You can get involved.”

Source: Ana Velázquez Mañana/X

Ana Velázquez Mañana is an Assistant Professor of Medicine in the UCSF Division of Hematology/Oncology at Zuckerberg San Francisco General and a thoracic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center. She serves as Assistant Director of Diversity, Equity, Inclusion, and Accessibility for Trainees of the UCSF Helen Diller Family Comprehensive Cancer Center and co-chairs the UCSF Department of Medicine Fellowship Diversity Committee. Her research, advocacy, and education efforts are focused on promoting and advancing health equity and workforce diversity. Dr. Velázquez is an active advocate for improving healthcare access and cancer care delivery for vulnerable populations.

About OncoDaily 

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.